Dozens of lawsuits that have been filed against manufacturers of low testosterone medication have been consolidated into one action. This step was taken after a panel of federal judges issued the order to do so. The cases will now become part of what is known as an MDL, or multi-district litigation. The purpose of MDLs is to allow for a large number of claims to be heard at once. This provides the defense with an opportunity to avoid defending an enormous number of cases individually. It also provides plaintiffs with an opportunity to avoid waiting for perhaps years before their claims even see a courtroom.
This low testosterone lawsuit consolidation order affects nearly 50 cases that have been filed against several manufacturers. This new MDL will take place in the Northern District of Illinois. This order also means that all of the claims will be heard before one judge. It is seen as somewhat rare that dozens of individual lawsuits filed against separate manufacturers of a product would be consolidated into one action. However, given the similarity of the medications and the problems that have been encountered by those who have undergone testosterone replacement therapy, or TRT, the judges felt that justice would be served by taking such a step.
The Basis of the Claims Against Testosterone Medication Manufacturers
Low-T lawsuits have been in the news in recent months because of several different studies that have been released to the public. These studies generally indicate that many people who undergo testosterone replacement therapy face a heightened risk for heart attacks, strokes and even death in some cases. One study found that risk to be nearly double even with younger men and men over the age of 65 with no heart-related health histories.
The claims that have been filed against the makers of such products as AndroGel, AndroDerm, Testim, Axiron and others generally allege that the makers of these medications either knew or should have known about the risks involved with using them. They further claim that the manufacturers did nothing about these risks and that they engaged in aggressive marketing campaigns designed to prompt more men to seek prescriptions for these medications.
The Potential Scope of the Problem
Based on the opinions of most business analysts, these marketing campaigns have been quite effective. It’s estimated that testosterone replacement therapy medications have generated billions of dollars in revenue for the companies that have released them onto the marketplace. It is also estimated that hundreds of thousands of men in the United States have undergone low-T therapy in an attempt to restore their testosterone levels to previous levels.
What the Low-T MDL Means For You
Unfortunately, there will likely be many more men who suffer the consequences of using these medications. If this includes you or someone you love, you still have time to act to protect your legal rights. If you find yourself in this position, you need to contact the testosterone replacement therapy lawyers at Parilman & Associates today to schedule a free initial consultation. You can either email the firm or call 800-800-DRUG.